Natus Medical (NTUS)
NASDAQ: NTUS
· Real-Time Price · USD
32.96
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Natus Medical Revenue Breakdown
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|
| Neurology Products Revenue | 284.77M | 236.16M | 287.24M | 279.8M | 243.16M | 238.52M | 237.3M | 232.67M |
| Neurology Products Revenue Growth | +20.58% | -17.78% | +2.66% | +15.07% | +1.94% | +0.51% | +1.99% | n/a |
| Newborn Care Products Revenue | 105.02M | 104.63M | 110.91M | 123.57M | 143.63M | 143.37M | 138.56M | 123.16M |
| Newborn Care Products Revenue Growth | +0.37% | -5.66% | -10.24% | -13.97% | +0.18% | +3.47% | +12.51% | n/a |
| OtometricsProducts Revenue | 83.65M | 74.89M | 97.03M | 127.53M | 114.18M | n/a | n/a | n/a |
| OtometricsProducts Revenue Growth | +11.69% | -22.81% | -23.92% | +11.68% | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 187.46M | 163.19M | 202.78M | 230.03M | 230.11M | 131.2M | 133.81M | 215.54M | 199.59M |
| Non-Us Revenue Growth | +14.87% | -19.52% | -11.85% | -0.03% | +75.39% | -1.96% | -37.92% | +7.99% | n/a |
| United States Revenue | 285.98M | 252.5M | 292.4M | 300.86M | 270.86M | 250.69M | 242.05M | n/a | n/a |
| United States Revenue Growth | +13.26% | -13.65% | -2.81% | +11.08% | +8.04% | +3.57% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 42.36M | 41.73M | 41.11M | 42.1M | 43.83M | 40.07M | 38.42M | 33.99M | 43.91M | 47.84M | 45.96M | 44.93M | 50.03M | 45.94M | 49M | 57.12M | 53.32M | 47.98M | 49.87M | 54.51M | 48.23M | 36.91M | 32.57M | 33.16M | 33.08M | 35.45M | 32.53M | 33.76M | 32.29M |
| Selling, General, and Administrative Revenue Growth | +1.50% | +1.50% | -2.34% | -3.94% | +9.36% | +4.31% | +13.03% | -22.60% | -8.20% | +4.08% | +2.30% | -10.21% | +8.91% | -6.25% | -14.22% | +7.13% | +11.12% | -3.78% | -8.52% | +13.02% | +30.68% | +13.33% | -1.79% | +0.25% | -6.70% | +9.00% | -3.67% | +4.55% | n/a |
| Research and Development Revenue | 13.22M | 13.75M | 14.27M | 14.25M | 14.04M | 14.72M | 14.67M | 14.34M | 17.57M | 18.79M | 14.11M | 12.77M | 13.06M | 15.3M | 15.13M | 15.62M | 15.44M | 13.72M | 11.63M | 13.71M | 12.75M | 10.85M | 7.69M | 7.11M | 7.8M | 8.57M | 7.7M | 7.31M | 6.86M |
| Research and Development Revenue Growth | -3.83% | -3.62% | +0.13% | +1.49% | -4.63% | +0.35% | +2.33% | -18.40% | -6.51% | +33.14% | +10.53% | -2.21% | -14.63% | +1.12% | -3.13% | +1.12% | +12.53% | +17.98% | -15.18% | +7.53% | +17.57% | +41.07% | +8.22% | -8.93% | -8.93% | +11.26% | +5.35% | +6.59% | n/a |
| Sales and Marketing Revenue | 29.55M | 29.3M | 28.26M | 29.49M | 28.97M | 27.71M | 26.04M | 22.8M | 30.73M | 32.3M | 30.85M | 32.24M | 33.73M | 34.21M | 33.2M | 33.4M | 35.87M | 31.06M | 32.54M | 30.35M | 32.22M | 23.26M | 19.75M | 21.24M | 20.6M | 22.33M | 22.5M | 22.11M | 20.74M |
| Sales and Marketing Revenue Growth | +0.87% | +3.66% | -4.16% | +1.78% | +4.53% | +6.45% | +14.18% | -25.80% | -4.85% | +4.69% | -4.31% | -4.43% | -1.39% | +3.03% | -0.60% | -6.89% | +15.49% | -4.54% | +7.19% | -5.78% | +38.52% | +17.78% | -7.02% | +3.11% | -7.77% | -0.73% | +1.75% | +6.59% | n/a |